Results 161 to 170 of about 343,349 (228)

Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up‐regulation of its ligands B7‐1 (CD80) and B7‐2 (CD86) on T cells

Clinical and Experimental Immunology, 1998
F. Moosig, E. Csernok, Guochun Wang, W. Gross   +3 more
semanticscholar   +1 more source

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery. [PDF]

Proc Natl Acad Sci U S A
Wang Y, Ogunnaike E, Yang H, Yuan S, Hong R, Barrett A, Ebong E, Liu B, Dotti G, Hu Q.   +9 more
europepmc   +1 more source

Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.

Kidney International, 2001
M. Girndt, M. Sester, U. Sester, H. Kaul, H. Köhler   +4 more
semanticscholar   +1 more source

Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses. [PDF]

Vaccines (Basel)
Despins CA, Round J, Dreolini L, Lee TS, Brown SD, Holt RA.   +5 more
europepmc   +1 more source

Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection.

Journal of Clinical Investigation, 1997
Gang Ye, C. Barrera, Xuejun Fan, William K. Gourley, Sheila E. Crowe, Peter B. Ernst, Victor E. Reyes   +6 more
semanticscholar   +1 more source

B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. [PDF]

Clin Cancer Res
Mehta S, Ippagunta S, Varadharajan S, Kardian A, Laboe N, Dinh D, Jones AB, Meehl MM, Ibañez J, Emanus E, Dao T, Ward MB, Orisme W, Lange S, Langfitt D, Steinberg J, Chiang J, Vogel P, Sheppard H, Ellison DW, Mack SC, Krenciute G.   +21 more
europepmc   +1 more source

Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling

Proceedings of the National Academy of Sciences of the United States of America, 2003
Xuewu Zhang, Jean-Claude D. Schwartz, S. Almo, S. Nathenson   +3 more
semanticscholar   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

Theranostics
Kim RK, Heo CK, Choi MJ, Kahm YJ, Kim MK, Lee M, Lee JY, Park H, Jung U, Shin BC, Kim BJ, Kim SC, Cho EW, Ryu CJ, Kim IG.   +14 more
europepmc   +1 more source

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Journal of Clinical Investigation, 1995
M. Racke, Dorothy E. Scott, Laura Quigley, Gary S. Gray, R. Abe, Carl H. June, P. Perrin   +6 more
semanticscholar   +1 more source

Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation. [PDF]

J Neurooncol
Liu J, Ha JH, Abikenari M, Sjoholm MA, Annagiri S, Ravi K, Bergsneider BH, Verma R, Theodros D, Medikonda R, Li G, Prolo LM, Monje M, Lim M.   +13 more
europepmc   +1 more source